CAS 2096989-55-6

Ticagrelor R,R,S,R-Isomer

CAS : 2096989-55-6

Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi

Formule : C₂₃H₂₈F₂N₆O₄S

Couleur et forme : White Off-White Light Yellow Solid

Masse moléculaire : 522.18608

Ref: 45-1666980

(1R,2R,3S,5R)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol

CAS : 2096989-55-6

Formule : C₂₃H₂₈F₂N₆O₄S

Degré de pureté : 98%

Masse moléculaire : 522.5680

Ref: IN-DA01D8YQ

(1R,2R,3S,5R)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol

CAS : 2096989-55-6

(1R,2R,3S,5R)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol

Degré de pureté : 98%

Ref: 54-PC1001126

ent-Ticagrelor

CAS : 2096989-55-6

Formule : C₂₃H₂₈F₂N₆O₄S

Couleur et forme : White To Off-White Solid

Masse moléculaire : 522.57

Ref: 4Z-T-814

(1R,2R,3S,5R)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol

CAS : 2096989-55-6

Degré de pureté : 98%

Masse moléculaire : 522.5700073

Ref: 10-F786825

ent-Ticagrelor

Produit contrôlé

CAS : 2096989-55-6

Applications ent-Ticagrelor is the enantiomer of Ticagrelor (T437700); the first reversible oral P2Y12 receptor antagonist that provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Used in the treatment of acute coronary syndromes (ACS).
References Matetzky, S., et al.: Circulation, 109, 3171 (2004); Bassand, J., et al.: Eur. Heart J., 28, 1598 (2007); Jakubowski, J., et al.: Cardiovasc. Drug Rev., 25, 357 (2007)

Formule : C₂₃H₂₈F₂N₆O₄S

Couleur et forme : Neat

Masse moléculaire : 522.57

Ref: TR-T437710

Ent-ticagrelor

CAS : 2096989-55-6

Ent-ticagrelor is a chirally pure pharmaceutical compound, categorized as a P2Y12 receptor antagonist, derived synthetically. This stereoisomer exemplifies the principle of stereochemistry in drug development, focusing on molecular specificity. Its mode of action involves selective binding to the P2Y12 adenosine diphosphate (ADP) receptors on platelets. This binding effectively inhibits the ADP-mediated activation of the GPIIb/IIIa receptor complex, which is crucial for platelet aggregation and clot formation.

Formule : C₂₃H₂₈F₂N₆O₄S

Degré de pureté : Min. 95%

Masse moléculaire : 522.6 g/mol

Ref: 3D-WID98955

Ticagrelor Enantiomer

CAS : 2096989-55-6

Formule : C₂₃H₂₈F₂N₆O₄S

Masse moléculaire : 522.57

Ref: ST-EA-CP-T21107

Ticagrelor Related Compound 34 (DP6)

CAS : 2096989-55-6

Formule : C₂₃H₂₆F₂N₆O₅S

Couleur et forme : White To Off-White Solid

Masse moléculaire : 536.56

Ref: 4Z-T-8149